Cargando…
Neonatal dexamethasone treatment exacerbates hypoxic-ischemic brain injury
BACKGROUND: The synthetic glucocorticoid dexamethasone (DEX) is commonly used to prevent chronic lung disease in prematurely born infants. Treatment regimens usually consist of high doses of DEX for several weeks, notably during a critical period of brain development. Therefore, there is some concer...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637314/ https://www.ncbi.nlm.nih.gov/pubmed/23594486 http://dx.doi.org/10.1186/1756-6606-6-18 |